Examination of the substrate specificity of heparin and heparan sulfate lyases
- PMID: 2334685
- DOI: 10.1021/bi00462a026
Examination of the substrate specificity of heparin and heparan sulfate lyases
Abstract
We have examined the activities of different preparations of heparin and heparan sulfate lyases from Flavobacterium heparinum. The enzymes were incubated with oligosaccharides of known size and sequence and with complex polysaccharide substrates, and the resulting degradation products were analyzed by strong-anion-exchange high-performance liquid chromatography and by oligosaccharide mapping using gradient polyacrylamide gel electrophoresis. Heparinase (EC 4.2.2.7) purified in our laboratory and a so-called Heparinase I (Hep I) from a commercial source yielded similar oligosaccharide maps with heparin substrates and displayed specificity for di- or trisulfated disaccharides of the structure----4)-alpha-D-GlcNp2S(6R)(1----4)-alpha-L-IdoAp2S( 1----(where R = O-sulfo or OH). Oligosaccharide mapping with two different commercial preparations of heparan sulfate lyase [heparitinase (EC 4.2.2.8)] indicated close similarities in their depolymerization of heparan sulfate. Furthermore, these enzymes only degraded defined oligosaccharides at hexosaminidic linkages with glucuronic acid:----4)-alpha-D-GlcNpR(1----4)-beta-D-GlcAp(1----(where R = N-acetamido or N-sulfo). The enzymes showed activity against solitary glucuronate-containing disaccharides in otherwise highly sulfated domains including the saccharide sequence that contains the antithrombin binding region in heparin. A different commercial enzyme, Heparinase II (Hep II), displayed a broad spectrum of activity against polysaccharide and oligosaccharide substrates, but mapping data indicated that it was a separate enzyme rather than a mixture of heparinase and heparitinase/Hep III. When used in conjunction with the described separation procedures, these enzymes are powerful reagents for the structural/sequence analysis of heparin and heparan sulfate.
Similar articles
-
Specificity studies on the heparin lyases from Flavobacterium heparinum.Biochemistry. 1993 Aug 17;32(32):8140-5. doi: 10.1021/bi00083a012. Biochemistry. 1993. PMID: 8347612
-
Purification and substrate specificity of heparitinase I and heparitinase II from Flavobacterium heparinum. Analyses of the heparin and heparan sulfate degradation products by 13C NMR spectroscopy.J Biol Chem. 1990 Oct 5;265(28):16807-13. J Biol Chem. 1990. PMID: 2211596
-
Isolation of the porcine heparin tetrasaccharides with glucuronate 2-O-sulfate. Heparinase cleaves glucuronate 2-O-sulfate-containing disaccharides in highly sulfated blocks in heparin.J Biol Chem. 1995 Apr 14;270(15):8696-705. J Biol Chem. 1995. PMID: 7721774
-
Heparin and heparan sulfate: structure and function.Nat Prod Rep. 2002 Jun;19(3):312-31. doi: 10.1039/b100916h. Nat Prod Rep. 2002. PMID: 12137280 Review.
-
Polysaccharide lyases.Appl Biochem Biotechnol. 1986 Apr;12(2):135-76. doi: 10.1007/BF02798420. Appl Biochem Biotechnol. 1986. PMID: 3521491 Review.
Cited by
-
Purification and partial characterization of the major cell-associated heparan sulphate proteoglycan of rat liver.Biochem J. 1991 Jan 15;273(Pt 2)(Pt 2):415-22. doi: 10.1042/bj2730415. Biochem J. 1991. PMID: 1846741 Free PMC article.
-
Isolation and Characterization of Heparan Sulfate from Human Lung Tissues.Molecules. 2021 Sep 10;26(18):5512. doi: 10.3390/molecules26185512. Molecules. 2021. PMID: 34576979 Free PMC article.
-
Mutual Inhibition of Antithrombin III and SARS-CoV-2 Cellular Attachment to Syndecans: Implications for COVID-19 Treatment and Vaccination.Int J Mol Sci. 2024 Jul 9;25(14):7534. doi: 10.3390/ijms25147534. Int J Mol Sci. 2024. PMID: 39062776 Free PMC article.
-
Role of cellular glycosaminoglycans and charged regions of viral G protein in human metapneumovirus infection.J Virol. 2008 Dec;82(23):11767-74. doi: 10.1128/JVI.01208-08. Epub 2008 Sep 10. J Virol. 2008. PMID: 18786997 Free PMC article.
-
Improved workup for glycosaminoglycan disaccharide analysis using CE with LIF detection.Electrophoresis. 2008 Nov;29(22):4538-48. doi: 10.1002/elps.200800335. Electrophoresis. 2008. PMID: 19035406 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical